AUTOIMMUNE INNER EAR DISEASE

AUTOIMMUNE INNER EAR DISEASE was reported 30 times

AUTOIMMUNE INNER EAR DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
1 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
2 Interleukin-17A Antagonist [EPC] 3 0.0001
3 Sympathomimetic-like Agent [EPC] 2 0.0001
4 Progesterone [EPC] 1 0.0000
5 Interleukin-12 Antagonist [EPC] 4 0.0000
6 Interleukin-23 Antagonist [EPC] 4 0.0000
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
8 Anti-IgE [EPC] 2 0.0000
9 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
10 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
11 Aminosalicylate [EPC] 2 0.0000
12 Nicotinic Acid [EPC] 1 0.0000
13 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
14 Estrogen [EPC] 2 0.0000
15 Acetylcholine Release Inhibitor [EPC] 1 0.0000
16 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
17 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
18 Corticosteroid [EPC] 9 0.0000
19 Calcium [EPC] 1 0.0000
20 Vitamin D [EPC] 2 0.0000
21 beta-Adrenergic Blocker [EPC] 2 0.0000
22 Janus Kinase Inhibitor [EPC] 1 0.0000
23 Vitamin B12 [EPC] 2 0.0000
24 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
25 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
26 Vitamin C [EPC] 2 0.0000
27 Retinoid [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 2 0.0000
29 Proton Pump Inhibitor [EPC] 2 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 GLP-1 Receptor Agonist [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000